Veterans Perceptions of Satisfaction and Convenience with Anticoagulants for Atrial Fibrillation: Warfarin versus Direct Oral Anticoagulants

References

• Danelich IM, Reed BN, Hollis IB, Cook AM, Rodgers JE. Clinical update on the management of atrial fibrillation. Pharmacotherapy. 2013;33(4):422–446. doi:10.1002/phar.1217
   Web of Science ®Google Scholar
• Quinn GR, Fang MC. Atrial fibrillation: stroke prevention in older adults. Clinics in Geriatric Medicine. 2012;28(4):617–634.
   Web of Science ®Google Scholar
• Lu Y, Branstad R, Karim RM, Asinger RW. Consideration of clinical variables for choosing new anticoagulant alternatives to warfarin for the management of non-valvular atrial fibrillation. Journal of Clinical Pharmacy and Therapeutics. 2014;39(6):628–636. doi:10.1111/jcpt.12207
   PubMed Web of Science ®Google Scholar
• Proietti M, Lane DA, Boriani G, Lip GYH. Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines. Can J Cardiol. 2019;35(5):619–633. doi:10.1016/j.cjca.2019.02.009
   PubMed Web of Science ®Google Scholar
• Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955–962. doi:10.1016/S0140-6736(13)62343-0
   PubMed Web of Science ®Google Scholar
• Munn D, Abdul-Rahim AH, Fischer U, Werring DJ, Robinson TG, Dawson J. A survey of opinion: when to start oral anticoagulants in patients with acute ischaemic stroke and atrial fibrillation? Eur Stroke J. 2018;3(4):355–360. doi:10.1177/2396987318787124
   Web of Science ®Google Scholar
• Devereaux PJ, Anderson DR, Gardner MJ, et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study Commentary: varied preferences reflect the reality of clinical practice. BMJ (Clinical Research Ed. 2001;323(7323):1218–1222. doi:10.1136/bmj.323.7323.1218
   PubMed Web of Science ®Google Scholar
• Borg Xuereb C, Shaw RL, Lane DA. Patients’ and health professionals’ views and experiences of atrial fibrillation and oral-anticoagulant therapy: a qualitative meta-synthesis. Patient Educ Couns. 2012;88(2):330–337. doi:10.1016/j.pec.2012.05.011
   Web of Science ®Google Scholar
• Larochelle J, Brais C, Blais L, et al. Patients’ Perception of Newly Initiated Oral Anticoagulant Treatment for Atrial Fibrillation: an Observational Study. J Gen Intern Med. 2018;33(8):1239–1241. doi:10.1007/s11606-018-4457-z
   Web of Science ®Google Scholar
• Mas Dalmau G, Sant Arderiu E, Enfedaque Montes MB, Sola I, Pequeno Saco S, Alonso Coello P. Patients’ and physicians’ perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review. BMC Family Practice. 2017;18(1):3. doi:10.1186/s12875-016-0574-0
   Web of Science ®Google Scholar
• Bajorek B, Saxton B, Anderson E, Chow CK. Patients’ preferences for new versus old anticoagulants: a mixed-method vignette-based study. Eur J Cardiovasc Nurs. 2018;17(5):429–438. doi:10.1177/1474515117739618
   Web of Science ®Google Scholar
• Boom MS, Berghuis EM, Nieuwkerk PT, Pinedo S, Buller HR. When do patients prefer a direct oral anticoagulant over a vitamin K antagonist? Neth J Med. 2015;73(8):368–372.
   PubMed Web of Science ®Google Scholar
• Palacio AM, Kirolos I, Tamariz L. Patient values and preferences when choosing anticoagulants. Patient Prefer Adherence. 2015;9:133–138.
   PubMed Web of Science ®Google Scholar
• Ng DL-C, Gan -G-G, Chai C-S, et al. Comparing quality of life and treatment satisfaction between patients on warfarin and direct oral anticoagulants: a cross-sectional study. Patient Prefer Adherence. 2019;13:1363–1373. doi:10.2147/PPA.S204246
   Web of Science ®Google Scholar
• Wright JN, Vazquez SR, Kim K, Jones AE, Witt DM. Assessing patient preferences for switching from warfarin to direct oral anticoagulants. Journal of Thrombosis and Thrombolysis. 2019;48(4):596–602. doi:10.1007/s11239-019-01915-9
   Web of Science ®Google Scholar
• MacLean S, Mulla S, Akl EA, et al. Patient values and preferences in decision making for antithrombotic therapy: a systematic review: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: american College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2):e1S–e23S. doi:10.1378/chest.11-2290
   Web of Science ®Google Scholar
• Seaburg L, Hess EP, Coylewright M, Ting HH, McLeod CJ, Montori VM. Shared decision making in atrial fibrillation: where we are and where we should be going. Circulation. 2014;129(6):704–710. doi:10.1161/CIRCULATIONAHA.113.004498
   PubMed Web of Science ®Google Scholar
• Prisco D, Cenci C, Silvestri E, Ciucciarelli L, Di Minno G. Novel oral anticoagulants in atrial fibrillation: which novel oral anticoagulant for which patient? J Cardiovasc Med (Hagerstown). 2015;16(7):512–519. doi:10.2459/JCM.0000000000000262
   Web of Science ®Google Scholar
• Turagam MK, Velagapudi P, Flaker GC. Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants. Clin Interv Aging. 2015;10:1431–1444.
   PubMed Web of Science ®Google Scholar
• Olenick M, Flowers M, Diaz VJ. US veterans and their unique issues: enhancing health care professional awareness. Adv Med Educ Pract. 2015;6:635–639. doi:10.2147/AMEP.S89479
   PubMed Web of Science ®Google Scholar
• Prins MH, Guillemin I, Gilet H, et al. Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q©). Health Qual Life Outcomes. 2009;7(1):30. doi:10.1186/1477-7525-7-30
   Web of Science ®Google Scholar
• Prins MH, Marrel A, Carita P, et al. Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the ‘Perception of Anticoagulant Treatment Questionnaire‘ (PACT-Q©). Health Qual Life Outcomes. 2009;7(1):9. doi:10.1186/1477-7525-7-9
   Web of Science ®Google Scholar
• Benzimra M, Bonnamour B, Duracinsky M, et al. Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation. Patient Prefer Adherence. 2018;12:79–87. doi:10.2147/PPA.S131158
   PubMed Web of Science ®Google Scholar
• Goette A, Kwong WJ, Ezekowitz MD, et al. Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study. Europace. 2018;20(12):1936–1943. doi:10.1093/europace/euy141
   Web of Science ®Google Scholar
• Riva N, Borg Xuereb C, Makris M, Ageno W, Gatt A. Reliability and validity of the Maltese version of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q). Patient Prefer Adherence. 2019;13:969–979. doi:10.2147/PPA.S207498
   PubMed Web of Science ®Google Scholar
• Healthcare Cost and Utilization Project (HCUP). AHRQ Comorbidity Software, Version 3.7. http://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp.2017. Accessed May 13, 2013..
   Google Scholar
• Dillman D. Mail and Internet Surveys: The Tailored Design Method.. 2nd ed. New York: John Wiley & Sons, Inc; 2000.
   Google Scholar
• Holder KA. United States Census Bureau, Social, Economic and Housing Statistics Division: Who Are Veterans? 2016. Available from https://www.census.gov/newsroom/blogs/random-samplings/2016/11/who_are_veterans.html. Accessed October 09, 2020.
   Google Scholar
• Chen J, Zhuang X, Long M, Su C, Wang WL. Efficacy and Safety of Edoxaban in Nonvalvular Atrial Fibrillation: A Meta-analysis of Randomized Controlled Trials. J Stroke Cerebrovasc Dis. 2015;24(12):2710–2719. doi:10.1016/j.jstrokecerebrovasdis.2015.07.026
   PubMed Web of Science ®Google Scholar
• Petersen H, Mental Health VA Featured Article: late Life Depression. https://www.mentalhealth.va.gov/featureArticle_Mar11LateLife.asp. 2011. Accessed Oct 21, 2019..
   Google Scholar
• Noseworthy PA, Brito JP, Kunneman M, et al. Shared decision-making in atrial fibrillation: navigating complex issues in partnership with the patient. J Int Cardiac Electrophysiol. 2019;56(2):159–163. doi:10.1007/s10840-018-0465-5
   Web of Science ®Google Scholar